<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease were treated with <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> alone </plain></SENT>
<SENT sid="1" pm="."><plain>At the therapeutic drug level of 0.2 mg/kg, seven patients developed <z:hpo ids='HP_0000798'>oligospermia</z:hpo> and three patients developed <z:hpo ids='HP_0000027'>azoospermia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Histopathology revealed evidence of <z:hpo ids='HP_0000029'>testicular atrophy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Fifteen (75%) out of 20 eyes had a visual acuity of 20/200 or less following therapy </plain></SENT>
<SENT sid="5" pm="."><plain>It is concluded that <z:chebi fb="5" ids="28830">chlorambucil</z:chebi> should not be used as the first line of therapy in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and that its long term benefits in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease should be reevaluated </plain></SENT>
</text></document>